Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer

This hypofractionated regimen provides excellent biochemical control in favorable risk prostate cancer with an acceptable rate of late toxicity. Further studies exploring this hypofractionation regimen are warranted.